{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:56:03Z","timestamp":1777870563457,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004870","name":"Research Foundation of The City University of New York","doi-asserted-by":"publisher","award":["TRADB-48-360"],"award-info":[{"award-number":["TRADB-48-360"]}],"id":[{"id":"10.13039\/100004870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006462","name":"City University of New York","doi-asserted-by":"publisher","award":["80212-03-17"],"award-info":[{"award-number":["80212-03-17"]}],"id":[{"id":"10.13039\/100006462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13104-019-4241-0","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T13:03:47Z","timestamp":1554728627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of vitamin D3 and its chemical analogs on the growth of Hodgkin\u2019s lymphoma, in vitro"],"prefix":"10.1186","volume":"12","author":[{"given":"Rajendra","family":"Gharbaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onyekwere","family":"Onwumere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Mighty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Redenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"issue":"3","key":"4241_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/ejh.12818","volume":"98","author":"PM Kulling","year":"2017","unstructured":"Kulling PM, et al. Vitamin D in hematological disorders and malignancies. Eur J Haematol. 2017;98(3):187\u201397.","journal-title":"Eur J Haematol"},{"issue":"27","key":"4241_CR2","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1200\/JCO.2010.28.6674","volume":"28","author":"MT Drake","year":"2010","unstructured":"Drake MT, et al. Vitamin D insufficiency and prognosis in non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2010;28(27):4191\u20138.","journal-title":"J Clin Oncol"},{"issue":"12","key":"4241_CR3","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1002\/cncr.29320","volume":"121","author":"IM Shui","year":"2015","unstructured":"Shui IM, et al. Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer. 2015;121(12):1949\u201356.","journal-title":"Cancer"},{"issue":"11","key":"4241_CR4","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1038\/bjc.2014.175","volume":"110","author":"Y Kim","year":"2014","unstructured":"Kim Y, Je Y. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Br J Cancer. 2014;110(11):2772\u201384.","journal-title":"Br J Cancer"},{"key":"4241_CR5","doi-asserted-by":"crossref","first-page":"117822341774981","DOI":"10.1177\/1178223417749816","volume":"11","author":"M Atoum","year":"2017","unstructured":"Atoum M, Alzoughool F. Vitamin D and breast cancer: latest evidence and future steps. Breast Cancer. 2017;11:1178223417749816.","journal-title":"Breast Cancer"},{"issue":"10 Suppl 2","key":"4241_CR6","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1111\/j.1753-4887.2008.00094.x","volume":"66","author":"S Samuel","year":"2008","unstructured":"Samuel S, Sitrin MD. Vitamin D\u2019s role in cell proliferation and differentiation. Nutr Rev. 2008;66(10 Suppl 2):S116\u201324.","journal-title":"Nutr Rev"},{"key":"4241_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/1471-2407-12-215","volume":"12","author":"C Renne","year":"2012","unstructured":"Renne C, Benz AH, Hansmann ML. Vitamin D3 receptor is highly expressed in Hodgkin\u2019s lymphoma. BMC Cancer. 2012;12:215.","journal-title":"BMC Cancer"},{"key":"4241_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1756-8722-6-62","volume":"6","author":"R Gharbaran","year":"2013","unstructured":"Gharbaran R, et al. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+\/CD30+ cells in poor outcome Hodgkin lymphoma patients. J Hematol Oncol. 2013;6:62.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"4241_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1046\/j.1365-2249.2001.01671.x","volume":"126","author":"R Consolini","year":"2001","unstructured":"Consolini R, et al. Effects of vitamin D on the growth of normal and malignant B-cell progenitors. Clin Exp Immunol. 2001;126(2):214\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"4241_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/bjc.1993.406","volume":"68","author":"T Hickish","year":"1993","unstructured":"Hickish T, et al. The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer. 1993;68(4):668\u201372.","journal-title":"Br J Cancer"},{"key":"4241_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jsbmb.2015.10.015","volume":"164","author":"P Kozielewicz","year":"2016","unstructured":"Kozielewicz P, et al. Novel vitamin D analogues; cytotoxic and anti-proliferative activity against a diffuse large B-cell lymphoma cell line and B-cells from healthy donors. J Steroid Biochem Mol Biol. 2016;164:98\u2013105.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4616","key":"4241_CR12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1126\/science.6310748","volume":"221","author":"DM Provvedini","year":"1983","unstructured":"Provvedini DM, et al. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983;221(4616):1181\u20133.","journal-title":"Science"},{"issue":"6","key":"4241_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s004030050206","volume":"289","author":"H Solvsten","year":"1997","unstructured":"Solvsten H, et al. Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes. Arch Dermatol Res. 1997;289(6):367\u201372.","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"4241_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.4049\/jimmunol.1401923","volume":"194","author":"S Thangamani","year":"2015","unstructured":"Thangamani S, et al. Cutting edge: progesterone directly upregulates vitamin d receptor gene expression for efficient regulation of T cells by calcitriol. J Immunol. 2015;194(3):883\u20136.","journal-title":"J Immunol"},{"issue":"7","key":"4241_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1158\/1940-6207.CAPR-12-0493","volume":"6","author":"LR Lee","year":"2013","unstructured":"Lee LR, et al. Progesterone enhances calcitriol antitumor activity by upregulating vitamin D receptor expression and promoting apoptosis in endometrial cancer cells. Cancer Prev Res. 2013;6(7):731\u201343.","journal-title":"Cancer Prev Res"},{"issue":"2","key":"4241_CR16","first-page":"172","volume":"1816","author":"S Mocellin","year":"2011","unstructured":"Mocellin S. Vitamin D and cancer: deciphering the truth. Biochim Biophys Acta. 2011;1816(2):172\u20138.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4241_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/jcb.240490109","volume":"49","author":"K Kragballe","year":"1992","unstructured":"Kragballe K. Vitamin D analogues in the treatment of psoriasis. J Cell Biochem. 1992;49(1):46\u201352.","journal-title":"J Cell Biochem"},{"issue":"2","key":"4241_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/bcpt.13007","volume":"123","author":"I Emanuelsson","year":"2018","unstructured":"Emanuelsson I, et al. Vitamin D analogues tacalcitol and calcipotriol inhibit proliferation and migration of T98G human glioblastoma cells. Basic Clin Pharmacol Toxicol. 2018;123(2):130\u20136.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"7","key":"4241_CR19","first-page":"1486","volume":"7","author":"M Segovia-Mendoza","year":"2017","unstructured":"Segovia-Mendoza M, et al. The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast cancer cells. Am J Cancer Res. 2017;7(7):1486\u2013500.","journal-title":"Am J Cancer Res"},{"issue":"7","key":"4241_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2174\/1381612003400371","volume":"6","author":"CM Hansen","year":"2000","unstructured":"Hansen CM, et al. Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation. Curr Pharm Des. 2000;6(7):803\u201328.","journal-title":"Curr Pharm Des"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-019-4241-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T23:21:23Z","timestamp":1586215283000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-019-4241-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4241"],"URL":"https:\/\/doi.org\/10.1186\/s13104-019-4241-0","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"10 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"216"}}